In this interview, News Medical speaks with Mohammad Aklaq at LabGenius Therapeutics about how automation and machine learning are pioneering the discovery of complex antibodies following the company’s recent expansion of its EVA™ platform.
To start, can you tell us a little about your role at LabGenius Therapeutics and what excites you most about working on automation in antibody discovery?
At LabGenius Therapeutics, I’m focused on applying my expertise and…
Article Source
https://www.news-medical.net/news/20250401/Supercharging-Next-Gen-Antibody-Discovery-with-AI-and-High-Throughput-Experimentation.aspx
